HNSBF
Price
$2.74
Change
-$0.26 (-8.67%)
Updated
Jul 17 closing price
Capitalization
236.87M
PMVP
Price
$1.33
Change
-$0.00 (-0.00%)
Updated
Jul 18 closing price
Capitalization
69.1M
17 days until earnings call
Interact to see
Advertisement

HNSBF vs PMVP

Header iconHNSBF vs PMVP Comparison
Open Charts HNSBF vs PMVPBanner chart's image
Hansa Medical AB
Price$2.74
Change-$0.26 (-8.67%)
Volume$7.12K
Capitalization236.87M
PMV Pharmaceuticals
Price$1.33
Change-$0.00 (-0.00%)
Volume$173.57K
Capitalization69.1M
HNSBF vs PMVP Comparison Chart in %
Loading...
HNSBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HNSBF vs. PMVP commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSBF is a Hold and PMVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (HNSBF: $2.74 vs. PMVP: $1.33)
Brand notoriety: HNSBF and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HNSBF: 896% vs. PMVP: 63%
Market capitalization -- HNSBF: $236.87M vs. PMVP: $69.1M
HNSBF [@Biotechnology] is valued at $236.87M. PMVP’s [@Biotechnology] market capitalization is $69.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSBF’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • HNSBF’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, PMVP is a better buy in the long-term than HNSBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HNSBF’s TA Score shows that 1 TA indicator(s) are bullish while PMVP’s TA Score has 5 bullish TA indicator(s).

  • HNSBF’s TA Score: 1 bullish, 4 bearish.
  • PMVP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than HNSBF.

Price Growth

HNSBF (@Biotechnology) experienced а -8.67% price change this week, while PMVP (@Biotechnology) price change was +5.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSBF($237M) has a higher market cap than PMVP($69.1M). HNSBF YTD gains are higher at: -8.667 vs. PMVP (-11.921). PMVP has higher annual earnings (EBITDA): -87.97M vs. HNSBF (-523.23M). HNSBF has more cash in the bank: 250M vs. PMVP (160M). PMVP has less debt than HNSBF: PMVP (1.11M) vs HNSBF (1.02B). HNSBF has higher revenues than PMVP: HNSBF (182M) vs PMVP (0).
HNSBFPMVPHNSBF / PMVP
Capitalization237M69.1M343%
EBITDA-523.23M-87.97M595%
Gain YTD-8.667-11.92173%
P/E RatioN/AN/A-
Revenue182M0-
Total Cash250M160M156%
Total Debt1.02B1.11M92,043%
FUNDAMENTALS RATINGS
HNSBF: Fundamental Ratings
HNSBF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HNSBFPMVP
RSI
ODDS (%)
Bullish Trend 3 days ago
25%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
18%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
25%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
24%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
25%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
HNSBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BUFGX36.830.02
+0.05%
Buffalo Growth
GTEYX47.960.01
+0.02%
Gateway Y
TEMSX9.09-0.01
-0.11%
Nuveen Emerging Markets Eq Retiremt
CLPFX14.29-0.03
-0.21%
Catalyst Nasdaq-100 Hedged Equity I
HSMCX17.82-0.12
-0.67%
Hartford Small Company C

HNSBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSBF has been loosely correlated with CORT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSBF jumps, then CORT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSBF
1D Price
Change %
HNSBF100%
N/A
CORT - HNSBF
38%
Loosely correlated
-3.06%
AVXL - HNSBF
36%
Loosely correlated
-0.72%
PMVP - HNSBF
31%
Poorly correlated
N/A
MLLCF - HNSBF
28%
Poorly correlated
N/A
ELTX - HNSBF
27%
Poorly correlated
N/A
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
N/A
CLLS - PMVP
39%
Loosely correlated
-8.54%
LRMR - PMVP
37%
Loosely correlated
-3.31%
XNCR - PMVP
37%
Loosely correlated
-1.10%
TERN - PMVP
37%
Loosely correlated
+0.71%
ERAS - PMVP
36%
Loosely correlated
+4.17%
More